The NHS could be paying whopping higher prices for drugs if the UK’s £1.6billion post-Brexit trade deal with India goes ahead.
India supplies the NHS with a quarter of its medicines and changes to pharma monopoly rights and patent laws under leaked plans could see costs spiral.
Charities Oxfam and Médecins Sans Frontières UK are calling on International Trade Secretary Kemi Badenoch to withdraw the demands.